Tumor lysis syndrome is an oncologic emergency that every clinician will likely encounter at one time or another, and managing it requires careful consideration of a number of factors.
BeiGene Announces Expansion of Coverage on China s National Reimbursement Drug List – Form 8-K insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.
Four new indications added for tislelizumab and all nine approved indications now included in NRDL KYPROLIS included for the first time XGEVA successfully renewed BeiGene (NASDAQ: BGNE; HKEX:
With an abundance of targeted therapies transforming the treatment landscape for chronic lymphocytic leukemia, picking the optimal drug or regimen for the right situation can be a challenge.